Vaishali Pharma Limited IPO
Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established an office in Vietnam. At present they are supplying in around 10 countries.
In domestic markets, they are majorly into trading of APIs whereas, in export markets, they are into trading and marketing of APIs, formulations, surgical products and others. Recently they have applied for 186 registrations in 13 countries for some of their products and received 71 approvals from 7 countries.
They export Formulations, Surgical & APIs to Kenya, Sri Lanka, Russia, DR Congo, Myanmar, Tajikistan, Bangladesh, Kazakhstan, Cameroon, Jordan, Burkina -Faso, Nicaragua, Senegal, Pakistan, Ukraine, Yemen, Cambodia, Turkey, Congo, Zimbabwe, Ethiopia, Tanzania, Vietnam, Armenia, Costa Rica, Nigeria, C.A.R. and Guinea-Bissau.
Objects of the Vaishali Pharma Limited IPO:
Vaishali Pharma Limited IPO Details:
| Open Date: | Aug 07 2017 |
| Close Date: | Aug 10 2017 |
| Total Shares: | 1,976,000 |
| Face Value: | ₹ 10 Per Equity Share |
| Issue Type: | Book Built Issue IPO |
| Issue Size: | 14.23 Cr. |
| Lot Size: | 1600 Shares |
| Issue Price: | ₹ 71-72 Per Equity Share |
| Listing At: | NSE Emerge |
| Listing Date: | Aug 22 2017 |
Promoters And Management:
Financials of Vaishali Pharma Limited IPO:
| Particulars | For the year/period ended (in Rs. Lakhs) | |||||
|---|---|---|---|---|---|---|
| 31-Mar-17 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | ||
| Total Assets | 4464.87 | 4941.31 | 4579.50 | 5342.97 | 4858.17 | |
| Total Revenue | 6711.22 | 6989.13 | 9882.37 | 12156.90 | 11909.85 | |
| Profit After Tax | 66.37 | (3.03) | 16.15 | 30.05 | 60.00 | |
Lead Manager of Vaishali Pharma Limited IPO:
Registrar of Vaishali Pharma Limited IPO:
Company Address:
25th Sep 2018 - 27th Sep 2018 => Aavas Financiers IPO
